# Kennedy Plans to Reclassify 14 Peptide Drugs Weeks After 2023 Safety Removal - Date: 2026-04-06 - Category: Biotech & Life Sciences FDA’s own former acting commissioner warns reclassifying 14 unapproved peptides would undo six decades of drug-testing requirements. Meanwhile, a startup found 30% of consumer peptides are mislabeled or contaminated. ---